Cargando…

Altered profile of immune regulatory cells in the peripheral blood of lymphoma patients

BACKGROUND: Regulatory immune cells may modulate the lymphoma microenvironment and are of great interest due to the increasing prevalence of treatment with immunotherapies in lymphoma patients. The aim was to explore the composition of different immune regulatory cell subsets in the peripheral blood...

Descripción completa

Detalles Bibliográficos
Autores principales: Amini, R-M, Enblad, G., Hollander, P., Laszlo, S., Eriksson, E., Ayoola Gustafsson, K., Loskog, A., Thörn, I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449984/
https://www.ncbi.nlm.nih.gov/pubmed/30953461
http://dx.doi.org/10.1186/s12885-019-5529-0
_version_ 1783408964138958848
author Amini, R-M
Enblad, G.
Hollander, P.
Laszlo, S.
Eriksson, E.
Ayoola Gustafsson, K.
Loskog, A.
Thörn, I.
author_facet Amini, R-M
Enblad, G.
Hollander, P.
Laszlo, S.
Eriksson, E.
Ayoola Gustafsson, K.
Loskog, A.
Thörn, I.
author_sort Amini, R-M
collection PubMed
description BACKGROUND: Regulatory immune cells may modulate the lymphoma microenvironment and are of great interest due to the increasing prevalence of treatment with immunotherapies in lymphoma patients. The aim was to explore the composition of different immune regulatory cell subsets in the peripheral blood of newly diagnosed lymphoma patients in relation to treatment outcome. METHODS: Forty-three newly diagnosed patients with lymphoma were included in the study; 24 with high-grade B-cell lymphoma (HGBCL) and 19 with classical Hodgkin lymphoma (cHL). Peripheral blood was prospectively collected and immune regulatory cells were identified by multi-color flow cytometry and analyzed in relation to healthy blood donors and clinical characteristics and outcome. RESULTS: The percentage of CD3-positive T-cells was lower (p = 0.03) in the peripheral blood of lymphoma patients at diagnosis compared to healthy blood donors regardless of lymphoma subtype, although statistically, neither the percentage of monocytes (p = 0.2) nor the T-cell/monocyte ratio (p = 0.055) differed significantly. A significant decrease in the percentage of a subset of regulatory NK cells (CD7(+)/CD3(−)/CD56(bright)/CD16(dim/−)) was identified in the peripheral blood of lymphoma patients compared to healthy blood donors (p = 0.003). Lymphoma patients also had more granulocytic myeloid-derived suppressor cells (MDSCs) (p = 0.003) compared to healthy blood donors, whereas monocytic MDSCs did not differ significantly (p = 0.07). A superior disease-free survival was observed for cHL patients who had an increase in the percentage of granulocytic MDSCs (p = 0.04). CONCLUSIONS: An altered profile of immune cells in the peripheral blood with a decrease in T-cells and regulatory NK-cells was observed in newly diagnosed lymphoma patients. CHL patients with higher percentages of regulatory NK cells and higher percentages of granulocytic MDSCs might have a better outcome, although the number of patients was low. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12885-019-5529-0) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6449984
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-64499842019-04-16 Altered profile of immune regulatory cells in the peripheral blood of lymphoma patients Amini, R-M Enblad, G. Hollander, P. Laszlo, S. Eriksson, E. Ayoola Gustafsson, K. Loskog, A. Thörn, I. BMC Cancer Research Article BACKGROUND: Regulatory immune cells may modulate the lymphoma microenvironment and are of great interest due to the increasing prevalence of treatment with immunotherapies in lymphoma patients. The aim was to explore the composition of different immune regulatory cell subsets in the peripheral blood of newly diagnosed lymphoma patients in relation to treatment outcome. METHODS: Forty-three newly diagnosed patients with lymphoma were included in the study; 24 with high-grade B-cell lymphoma (HGBCL) and 19 with classical Hodgkin lymphoma (cHL). Peripheral blood was prospectively collected and immune regulatory cells were identified by multi-color flow cytometry and analyzed in relation to healthy blood donors and clinical characteristics and outcome. RESULTS: The percentage of CD3-positive T-cells was lower (p = 0.03) in the peripheral blood of lymphoma patients at diagnosis compared to healthy blood donors regardless of lymphoma subtype, although statistically, neither the percentage of monocytes (p = 0.2) nor the T-cell/monocyte ratio (p = 0.055) differed significantly. A significant decrease in the percentage of a subset of regulatory NK cells (CD7(+)/CD3(−)/CD56(bright)/CD16(dim/−)) was identified in the peripheral blood of lymphoma patients compared to healthy blood donors (p = 0.003). Lymphoma patients also had more granulocytic myeloid-derived suppressor cells (MDSCs) (p = 0.003) compared to healthy blood donors, whereas monocytic MDSCs did not differ significantly (p = 0.07). A superior disease-free survival was observed for cHL patients who had an increase in the percentage of granulocytic MDSCs (p = 0.04). CONCLUSIONS: An altered profile of immune cells in the peripheral blood with a decrease in T-cells and regulatory NK-cells was observed in newly diagnosed lymphoma patients. CHL patients with higher percentages of regulatory NK cells and higher percentages of granulocytic MDSCs might have a better outcome, although the number of patients was low. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12885-019-5529-0) contains supplementary material, which is available to authorized users. BioMed Central 2019-04-05 /pmc/articles/PMC6449984/ /pubmed/30953461 http://dx.doi.org/10.1186/s12885-019-5529-0 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Amini, R-M
Enblad, G.
Hollander, P.
Laszlo, S.
Eriksson, E.
Ayoola Gustafsson, K.
Loskog, A.
Thörn, I.
Altered profile of immune regulatory cells in the peripheral blood of lymphoma patients
title Altered profile of immune regulatory cells in the peripheral blood of lymphoma patients
title_full Altered profile of immune regulatory cells in the peripheral blood of lymphoma patients
title_fullStr Altered profile of immune regulatory cells in the peripheral blood of lymphoma patients
title_full_unstemmed Altered profile of immune regulatory cells in the peripheral blood of lymphoma patients
title_short Altered profile of immune regulatory cells in the peripheral blood of lymphoma patients
title_sort altered profile of immune regulatory cells in the peripheral blood of lymphoma patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449984/
https://www.ncbi.nlm.nih.gov/pubmed/30953461
http://dx.doi.org/10.1186/s12885-019-5529-0
work_keys_str_mv AT aminirm alteredprofileofimmuneregulatorycellsintheperipheralbloodoflymphomapatients
AT enbladg alteredprofileofimmuneregulatorycellsintheperipheralbloodoflymphomapatients
AT hollanderp alteredprofileofimmuneregulatorycellsintheperipheralbloodoflymphomapatients
AT laszlos alteredprofileofimmuneregulatorycellsintheperipheralbloodoflymphomapatients
AT erikssone alteredprofileofimmuneregulatorycellsintheperipheralbloodoflymphomapatients
AT ayoolagustafssonk alteredprofileofimmuneregulatorycellsintheperipheralbloodoflymphomapatients
AT loskoga alteredprofileofimmuneregulatorycellsintheperipheralbloodoflymphomapatients
AT thorni alteredprofileofimmuneregulatorycellsintheperipheralbloodoflymphomapatients